Tyers Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
Other funds holding CNCE
BI
ISL
Tyers Asset Management's CNCE Position: Q2 2018 in Review
Tyers Asset Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2018, closing a stake of 10,288 shares — an estimated $236K sold.
Tyers Asset Management first reported a position in CNCE in Q1 2018 and held it in 1 quarter. The position peaked at $236K in Q1 2018. 120 funds tracked by Wall St. Rank hold CNCE as of Q2 2018.
- Tyers Asset Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
- Tyers Asset Management sold 10,288 Concert Pharmaceuticals, Inc. shares in Q2 2018, an estimated $236K.
- Tyers Asset Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
- Tyers Asset Management's Concert Pharmaceuticals, Inc. position peaked at $236K in Q1 2018.
- 120 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2018.
Based on Tyers Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.